Autoimmune Diseases  >>  BMS-986142  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BMS-986142 / BMS
NCT02456844: Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients

Completed
1
24
US
Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142, Methotrexate, Leucovorin and BMS-986142
Bristol-Myers Squibb
Rheumatoid Arthritis
07/15
07/15
NCT02762123: A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates

Completed
1
28
US
BMS-986142 200mg, BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin), BMS-986142 350mg
Bristol-Myers Squibb
Rheumatoid Arthritis
08/16
08/16

Download Options